Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

CELIA C MAMBY

Allopathic & Osteopathic Physicians Internal Medicine Hematology & Oncology

NPI
1255319752
CMS profile
11702
Location
LITHONIA, GA

General Payments · PY2022–2024

$640.14

  • Reported across 22 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$511.41

17 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $386.69 15
Education $124.72 2

By paying entity

PY2024 · sorted by reported total

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2022 $23.51 1
PY2023 $105.22 4
PY2024 $511.41 17

Payment records · PY2024 (17)

Sorted by paying entity, then date · as published by CMS

Program year 2024 20222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
ABBVIE INC. $32.51 12/16/2024 Food and Beverage Undisputed 01/23/2026 1104950158 CMS
AstraZeneca Pharmaceuticals LP $22.09 02/06/2024 Food and Beverage Undisputed 01/23/2026 1104591000 CMS
Celgene Corporation $24.73 07/22/2024 Food and Beverage Undisputed 01/23/2026 1101143683 CMS
Daiichi Sankyo Inc. $27.76 01/08/2024 Food and Beverage Undisputed 01/23/2026 1089451834 CMS
Daiichi Sankyo Inc. $26.68 05/20/2024 Food and Beverage Undisputed 01/23/2026 1089451836 CMS
Daiichi Sankyo Inc. $21.09 11/11/2024 Food and Beverage Undisputed 01/23/2026 1089451832 CMS
Incyte Corporation $99.00 06/18/2024 Education Undisputed 01/23/2026 1141233185 CMS
Legend Biotech USA Inc. $17.97 11/25/2024 Food and Beverage Undisputed 01/23/2026 1131694025 CMS
Legend Biotech USA Inc. $25.72 11/25/2024 Education Undisputed 01/23/2026 1131695005 CMS
Merck Sharp & Dohme LLC $31.01 07/08/2024 Food and Beverage Undisputed 01/23/2026 1141918924 CMS
Novartis Pharmaceuticals Corporation $29.01 08/12/2024 Food and Beverage Undisputed 01/23/2026 1087119630 CMS
PUMA BIOTECHNOLOGY, INC. $19.57 09/09/2024 Food and Beverage Undisputed 01/23/2026 1113843686 CMS
Regeneron Healthcare Solutions, Inc. $17.20 05/07/2024 Food and Beverage Undisputed 01/23/2026 1114107019 CMS
Takeda Pharmaceuticals U.S.A., Inc. $30.35 10/07/2024 Food and Beverage Undisputed 01/23/2026 1144962304 CMS
Tempus AI, Inc $20.64 02/14/2024 Food and Beverage Undisputed 01/23/2026 1150169194 CMS
Tempus AI, Inc $21.74 04/24/2024 Food and Beverage Undisputed 01/23/2026 1150169196 CMS
Tempus AI, Inc $44.34 08/24/2024 Food and Beverage Undisputed 01/23/2026 1150169198 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.